Pruebas En Casa. Resultados en 15 Minutos — eMed Te Trae la Prueba.
A través de un acuerdo exclusivo con Abbott, la plataforma de salud digital eMed proporciona un mayor acceso a BinaxNOW™, la primera prueba de COVID-19 en casa guiada virtualmente.
Si el resultado de su prueba es positivo, puede ser elegible para una prueba confirmatoria de amplificación de ácidos nucleicos (NAAT) de su empleador y Quest Diagnostics. Comuníquese con el departamento de Recursos Humanos o Salud y Seguridad de su empleador para obtener más información.
Qué Hay en la Caja
En el interior del envase, encontrarás todo lo que necesitas para realizar una prueba rápida de COVID-19, autorizada para el uso en una consulta virtual con un guía certificado de eMed.



BinaxNOWTM
COVID-19 Ag Card



Newly Designed Single-Use
Extraction Reagent Bottle



Nasal Swab
How Our Testing Process Works
Convenient. Guided. Reliable. The way testing should be.1. Answer a few questions
Complete our CDC Questionnaire to tell us about your symptoms and exposure.
2. Get a Prescribed Order
An eMed Healthcare Partner will determine if the test is right for you and issue a prescribed order.
3. Delivery or Pick-Up
The test is shipped within 24 hours, or pick it up locally.
4. Test at Home
Have a virtual visit guided by an eMed Certified Guide.
5. Get Results in 15 Minutes
Receive follow-up healthcare instructions and a digital pass, if your COVID-19 test is negative.
Learn More
Use the links below to learn more about Abbott's BinaxNOW COVID-19 Ag Card Home Test.

Frequently Asked Questions
On April 6, 2021, the FDA granted a 12-month shelf life to the BinaxNOW COVID-19 Home Test.
This means the expiry date you see printed on your test kits has been extended an additional three (3) months. For example, a test kit with an expiration date of 2021-09-27 (Sept. 27, 2021) will now expire 2021-12-27 (Dec. 27, 2021).
For additional information, review the letter issued by the FDA here: https://www.fda.gov/media/147409/download
Proper administration of the testing and accurate results reporting are absolutely necessary to help save lives and slow the spread of COVID-19. eMed’s Certified Guides help ensure the virtually guided testing sessions are administered and results read correctly so both the individual user and the broader public health system can be confident in the results.
eMed’s innovative digital point-of-care platform enables this supervision to occur remotely, protecting individuals from potential exposure in physical health care settings and enabling eMed to process millions of tests per day.
Anyone who administers their own test without an eMed Certified Guide will be ineligible to receive a digital NAVICA™ Pass of their negative result.
For more information about the Abbott NAVICA™ app and digital NAVICA™ Pass visit https://www.globalpointofcare.abbott/en/product-details/binaxnow-covid-19-home-test-us.html
We understand you may have been experiencing issues logging into your eMed account recently, and these issues have been resolved at this time. (As of Jan. 30, 2021)
Please try your log in again now. If the original credentials you created do not work, please create a new login with an updated username/password combination and login in with the updated information.
Login to your account at www.eMed.com and click the profile icon on the menu bar. Then, select “Edit eMed Profile”.
All test packs must be ordered on your behalf by your employer. Please contact your employer for more information.
You may contact eMed customer service at 1.866.955.1173 or via the eMed contact form for more information on your order status.
If you received an email with FedEx tracking information, you will be receiving a rapid antigen test pack on behalf of your employer. Please contact your employer for more information specific to your testing requirements.
- This product has not been FDA cleared or approved; but has been authorized by FDA under an EUA;
- This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and,
- This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.